###begin article-title 0
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Reversible gene knockdown in mice using a tight, inducible shRNA expression system
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
###end p 1
###begin p 2
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Insr</italic>
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
RNA interference through expression of short hairpin (sh)RNAs provides an efficient approach for gene function analysis in mouse genetics. Techniques allowing to control time and degree of gene silencing in vivo, however, are still lacking. Here we provide a generally applicable system for the temporal control of ubiquitous shRNA expression in mice. Depending on the dose of the inductor doxycycline, the knockdown efficiency reaches up to 90%. To demonstrate the feasibility of our tool, a mouse model of reversible insulin resistance was generated by expression of an insulin receptor (Insr)-specific shRNA. Upon induction, mice develop severe hyperglycemia within seven days. The onset and progression of the disease correlates with the concentration of doxycycline, and the phenotype returns to baseline shortly after withdrawal of the inductor. On a broad basis, this approach will enable new insights into gene function and molecular disease mechanisms.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 741 744 741 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5">3&#8211;5</xref>
###xml 830 834 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 884 887 884 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6 B7 B8">6&#8211;8</xref>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 713 718 <span type="species:ncbi:10090">mouse</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
The application of Cre/loxP recombination has refined the tools for manipulating the mouse genome, allowing to determine site and timing of gene alteration in the living animal (1,2). An inherent feature of these recombinase-based approaches, however, is a non-reversible gene switch that does not allow modulating gene expression in a given cell. In addition, the derivation of conditional mouse mutants is costly and time consuming due to extensive vector construction, ES cell manipulation and breeding. The finding that stably expressed short hairpin (sh) RNAs can mediate potent gene knockdown in transgenic animals opened the opportunity to reduce time and effort for the generation of genetically modified mouse models significantly (3-5). Conditional, RNAi-mediated gene knockdown in mice has been introduced by using Cre/loxP for tissue-specific control of shRNA expression (6-8). In contrast, temporal control of shRNA expression in transgenic animals has not been demonstrated so far.
###end p 5
###begin p 6
###xml 7 24 7 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Diabetes mellitus</italic>
###xml 453 454 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 942 944 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 945 947 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1376 1383 1373 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 739 744 <span type="species:ncbi:10090">mouse</span>
Type 2 Diabetes mellitus is a growing problem to public health, affecting more than 5% of western populations. Progressive, late onset insulin resistance and inadequate compensation through insulin secretion from pancreatic beta-cells leading to fasting hyperglycemia characterizes the course of the disease. Efforts of the pharmaceutical industry focus on the development of small molecules that increase the sensitivity of insulin receptor signaling (9). Here, animal models of insulin resistance are essential tools for understanding the molecular basis of the disease. Furthermore, drug target validation and evaluation of test compounds in appropriate disease model mice support the drug discovery process. The use of current genetic mouse models of type 2 diabetes is not optimal for this purpose as they do not allow modulating the onset and the degree of systemic insulin resistance, and the genetic modifications are not reversible (10,11). The first aspect is particularly important for developing therapeutic interventions during the early phase of the disease, whereas the latter would allow dissecting acute effects of insulin resistance from late diabetic symptoms such as neuropathy and arteriosclerosis. As the current technologies for gene manipulation do not facilitate these aspects, we established a new approach for temporal modulation of gene expression in vivo.
###end p 6
###begin p 7
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 230 235 230 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12 B13 B14 B15">12&#8211;15</xref>
###xml 190 197 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 636 651 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1028 1033 <span type="species:ncbi:10090">mouse</span>
In cultured cell lines, inducible expression of antisense or shRNAs has been achieved by using engineered, RNA polymerase III-dependent promoters containing operator sequences (tetO) of the E. coli tetracycline resistance operon (12-15). Binding of the tetracycline resistance operon repressor (tetR) to tetO blocks transcription, whereas de-repression is achievable by adding the inductor doxycycline (dox), causing release of TetR. Here we show that a codon optimized tet repressor, but not the wt coding region as employed in previous attempts, facilitates tight control of RNAi in different cell types and throughout development of transgenic mice. We found efficient, doxycycline-inducible silencing of both, a luciferase reporter and the insulin receptor gene, reaching 80-90% repression in most tissues. By introducing single-vector-constructs into the ES cell genome via recombinase mediated cassette exchange (RMCE) and applying tetraploid blastocyst complementation we demonstrate the rapid generation of a reversible mouse model of type 2 Diabetes mellitus within 3 months.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Rosa targeting and exchange vectors
###end title 9
###begin p 10
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rosa26 Rluc vector</italic>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Rosa26 Rluc vector: The Renilla luciferase gene (Promega) was inserted into the rosa26 targeting vector (5) 3' of the splice acceptor site. ShRNA cassettes were inserted 3' of the Renilla luciferase gene.
###end p 10
###begin p 11
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
ShRNA cassettes: The U6- and the H1-promoter fragments were amplified from human genomic DNA using a 3' primer containing the tet-operator sequences (bold: TATA-box, underlined: tet-operator):
###end p 11
###begin p 12
###xml 32 38 32 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ttataa</bold>
###xml 39 58 39 58 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tccctatcagtgatagaga</underline>
H1-tet: gaaatgtctttggatttgggaatcttataagtccctatcagtgatagagattccc
###end p 12
###begin p 13
###xml 30 39 30 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tttatatat</bold>
###xml 40 59 40 59 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tccctatcagtgatagaga</underline>
U6-tet: gaaagtatttcgatttcttggctttatatatctccctatcagtgatagagaaag
###end p 13
###begin p 14
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
Both fragments were cloned 5' of the Fluc-specific shRNA (16), followed by five thymidines as termination signal. Inducible shRNA expression cassettes were flanked by two loxP-sites (lox) to allow cre-mediated deletion.
###end p 14
###begin p 15
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reporter configuration</italic>
###xml 24 32 24 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Reporter configuration (Figure 1B): The firefly luciferase gene (Promega) was inserted into the rosa26-targeting vector (17) followed by the CAGGS-tetR cassette and a PGK-hygromycin resistance gene. 
###end p 15
###begin p 16
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reporter configuration</italic>
###xml 68 90 68 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">reporter configuration</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
Reporter configuration carrying itetR: Similar configuration as the reporter configuration described above, except that the tetR coding region is replaced by the codon optimized tet-repressor gene (itetR (18)).
###end p 16
###begin p 17
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ShRNA test vectors:</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Insr</italic>
ShRNA test vectors: The following shRNA sequences against the Insr mRNA (NM_010568) together with five thymidines for transcript termination were cloned 3' of pH1tetO:
###end p 17
###begin p 18
IR1: agtccgcatcgagaagaatattcaagagatattcttctcgatgcggact
###end p 18
###begin p 19
IR2: atcgagaagaataatgagctttcaagagaagctcattattcttctcgat
###end p 19
###begin p 20
IR3: actacattgtactgaacaattcaagagattgttcagtacaatgtagt
###end p 20
###begin p 21
IR4: agggcaagaccaactgtcctttcaagagaaggacagttggtcttgccct
###end p 21
###begin p 22
IR5: agaccagacccgaagatttcttcaagagagaaatcttcgggtctggtct
###end p 22
###begin p 23
IR6: agcctggctgccaccaatacttcaagagagtattggtggcagccaggct
###end p 23
###begin p 24
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pIR5</italic>
###xml 48 67 48 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet exchange vector</italic>
###xml 69 77 69 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
The resulting vectors are called pIR1-pIR6.pIR5-tet exchange vector (Figure 3A). The vector contains the F3 site and the FRT site in a similar configuration as described before (5). pIR5-tet was generated by insertion of the H1-tet-IR5 fragment from pIR5 into MCS of pINV-2 containing the following elements in 5' to 3' direction: synthetic polyA signal, F3-site, neomycin-resistance gene lacking the start ATG, hgH polyadenylation signal, MCS, CAGGS promoter (19), the codon optimized tet-repressor gene, synthetic polyA signal, FRT-site.
###end p 24
###begin p 25
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pFluc-tet exchange vector</italic>
###xml 27 35 27 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 68 92 68 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pIR5-tet exchange vector</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
pFluc-tet exchange vector (Figure 2A): Similar configuration as the pIR5-tet exchange vector, except a Fluc-specific shRNA (16) instead of IR5. 
###end p 25
###begin title 26
Cell culture
###end title 26
###begin p 27
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
ES cell culture was carried out as described before (20). Transfection of Art4.12 ES cells carrying the FRT/F3 configuration at rosa26 was performed as described (5).
###end p 27
###begin title 28
Doxycycline treatment of ES cells
###end title 28
###begin p 29
###xml 86 90 <span type="species:ncbi:9913">calf</span>
Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS), 4500 mg/l glucose, 1x non-essential amino acids and 1 microg/ml doxycycline (Sigma D-9891) for 48 h. Medium containing doxycycline was prepared and changed every day.
###end p 29
###begin title 30
Transient transfection of muscle cells
###end title 30
###begin p 31
###xml 46 47 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 192 193 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
C2C12 myoblasts were grown at 37degreesC/5% CO2 in DMEM containing 10% FCS, 4500 mg/l glucose and 1x non-essential amino acids (GIBCO BRL). Transfection studies were carried out with 1.35 x 105 cells plated on a 6-well plate. Cells were transfected with 2.5 microg DNA (1.25 microg GFP-vector + 1.25 microg of either shRNA expression vector pIR1 to 6). DNA was mixed with 10 microl Lipofectamin (Invitrogen, #18324-111) and 200 microl Optimem (Gibco BRL, #51985-026) and incubated for 45 min at RT. For transfection, cells were washed with 1x PBS and incubated for 5 h in 2 ml starving medium containing the Optimen-DNA-Solution. After 5 h, medium DMEM with 20% FCS was added to the cells. Twenty four hours after transfection, cells were washed with 1 x PBS and fixed with methanol for 3 min, washed with 1x PBS and dried. Cells were stained with DAPI in Vectashield (Vector). Cells were analyzed for GFP expression and transfection efficiency.
###end p 31
###begin title 32
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 32
###begin p 33
###xml 77 81 <span type="species:ncbi:10090">Mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
All animal studies were approved according to the German Animal Welfare Act. Mice were kept in the animal facility at Artemis Pharmaceuticals GmbH in microisolator cages (Tecniplast Sealsave). B6D2F1 mice for the generation of tetraploid blastocysts were obtained from Harlan, NL.
###end p 33
###begin title 34
Doxycycline treatment
###end title 34
###begin p 35
Solutions containing 2 mg/ml doxycycline (Sigma D-9891), 10% sucrose or 20 microg/ml doxycycline, 1% sucrose or 2 microg/ml doxycycline, 0.1% sucrose in drinking water were prepared every second day and kept dark.
###end p 35
###begin title 36
Luciferase detection
###end title 36
###begin p 37
###xml 62 63 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 65 66 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 156 157 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Organs were homogenized at 4degreesC in lysis buffer (0.1 M KH2PO4, 1 mM DTT, 0.1% Triton X-100) using a tissue grinder and centrifuged for 5 min at 2000 x g (4degreesC). Supernatant was assayed for Fluc activities using the Dual Luciferase Assay (Promega, Inc.) according to the manufacturer's protocol. The luminescence was detected using a Lumat LB 9507 (EG&G Berthold). Relative values of firefly luciferase activity in different organs are given as indicated. All values of Fluc activity were normalized by using the Rluc activity for reference.
###end p 37
###begin title 38
Protein isolation
###end title 38
###begin p 39
Cells were lysed in protein extraction buffer containing 1% Triton X-100, 0.1% SDS, 10 mM Tris-HCl pH 7.4, 1.25 mM Tris Base, 10 mM EDTA, 50 mM NaCl, 50 mM NaF, 50 microg Aprotinin. Protein concentration was calculated according to Warburg-Christian.
###end p 39
###begin title 40
Western blot
###end title 40
###begin p 41
###xml 389 393 <span type="species:ncbi:9925">Goat</span>
###xml 399 405 <span type="species:ncbi:9986">rabbit</span>
###xml 551 555 <span type="species:ncbi:9925">goat</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
Proteins were fractionated on a 10% SDS-PAGE gel and semi-dry blotted for 30 min at 200 mA. Primary antibodies: alphaINSR (Rbeta (C-19) #sc-711, Santa Cruz Biotechnology) was diluted 1:200, alphaAKT (AKT/Proteinkinase B: AKT #9272, Cell Signaling Technology) 1:1000, tet02 (Mobitec, #tet02) 1:500 and beta-Actin 1:500 (Santa Cruz Biotechnology #sc-47778) in TBS containing 2% milk powder. Goat anti-rabbit IgG (whole molecule)-peroxidase (Sigma, #A6154-1ML) was used as secondary antibody to detect INSR and AKT. For detection of tetR and beta-Actin, goat anti-mouse IgG (Mobitec #A1-900) was diluted 1:1000 in 2% MP/TBS and detected using ECL reagents (Amersham, #RPN 2105).
###end p 41
###begin title 42
RNA isolation
###end title 42
###begin p 43
###xml 559 560 547 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Total RNA was isolated with peqGOLD TriFast (peqLab, #30-2020) using 2.5 ml for a confluent grown 10-cm plate. Cells were centrifuged for 15 min at 13 000 r.p.m. and 4degreesC. Supernatant was transferred in a siliconized 2 ml Eppendorf tube and 0.3x volume Chloroform was added to the supernatant. The solution was mixed and centrifuged for 15 min at 13 000 r.p.m. and 4degreesC. The supernatant was transferred into a new siliconized 1.5 ml tube and protein was precipitated by adding the same volume of isopropanol. RNA was subsequently dissolved in DEPC-H2O.
###end p 43
###begin title 44
Northern blot
###end title 44
###begin p 45
###xml 118 119 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 529 531 511 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
A 30 microg RNA was fractionated on a 15% denaturating polyacrylamide gel and blotted on a nylon membrane at 3.3 mA/cm2 for 35 min. RNA was cross-linked to the membrane using UV-light and incubated at 80degreesC for 30 min. The membrane was subsequently incubated for 2 h in 10 ml pre-hybridization solution and labeled using radioactive, oligo probes against antisense strand of shRNA-IR5 (gaccagacccgaagatttct) and against 5srRNA (tcctgcaattcacattaattctcgcagctagc). A 10 U T4-Polynucleotide-kinase (NEB) and 10 microCi gamma- (32P)-ATP (10 U microCi/microl) were used for probe labeling.
###end p 45
###begin title 46
Reverse transcription
###end title 46
###begin p 47
###xml 182 186 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Insr</italic>
###xml 220 221 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
cDNA was synthesized using the Reverse Transcription Core Kit (Eurogentec). A real-time reaction of 20 microl contained the following components: 1 microl cDNA, 1 microl Probe (alphaInsr, Mm 00439693-m1), 8 microl DEPC-H2O and 10 microl qPCR Mastermix Plus (Eurogentec). Real-time PCR reactions were performed using an iCycler Thermal cycler instrument (Bio-Rad).
###end p 47
###begin title 48
Measurement of insulin levels in plasma
###end title 48
###begin p 49
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 65 70 <span type="species:ncbi:10090">Mouse</span>
Plasma mouse insulin levels were determined by using the Insulin Mouse Ultrasensitive ELISA kit (DRG Diagnostics) according to the manufacturer's protocol.
###end p 49
###begin title 50
RESULTS
###end title 50
###begin title 51
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Establishing a configuration for inducible shRNA expression in mice
###end title 51
###begin p 52
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 299 317 299 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla reniformis</italic>
###xml 352 360 352 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 455 458 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 597 603 597 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rosa26</italic>
###xml 673 681 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 299 317 <span type="species:ncbi:6136">Renilla reniformis</span>
We inserted tetO sequences 3' of the TATA box of the human H1- and U6-promoter (H1-tet, U6-tet), similar to the constructs described in two recent publications (12,13). Both promoter constructs were tested using a dual reporter system consisting of firefly luciferase (Fluc) as a test substrate and Renilla reniformis luciferase (Rluc) as a reference (Figure 1A). A firefly-luciferase-specific shRNA sequence (16) under the control of either H1-tet or U6-tet along with the luciferase reporter constructs and a gene encoding a codon-optimized version of tetR (itetR (18)) were introduced into the Rosa26 locus through homologous recombination in embryonic stem (ES)-cells (Figure 1B and C).
###end p 52
###begin p 53
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
We have chosen rosa26 for this purpose as this locus mediates ubiquitous transgene expression in vivo using RNA polymerase II- as well as RNA polymerase III-dependent promoters (5,17). In contrast to random transgenesis that often results in variable transgene expression due to copy number, configuration and integration site, we expected this strategy to facilitate an optimal shRNA expression.
###end p 53
###begin p 54
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 349 357 349 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 412 420 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 443 446 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 632 640 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 717 725 717 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 811 812 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1014 1022 1014 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1157 1158 1157 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1361 1369 1361 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
Recombinant ES cells were injected into blastocysts and chimeric mice were obtained upon transfer of blastocysts into pseudopregnant females using standard protocols (20). The activity of firefly luciferase was determined in different organs of the resulting mice. While the U6-tet promoter showed residual activity even in the absence of inductor (Figure 2B), regulation of H1-tet appeared tight in all organs (Figure 2A). The activity of H1-tet was undetectable before induction, but mediated a similar pattern of RNAi in the presence of doxycycline as the wild-type (constitutive) human H1 promoter in all tissues, except brain (Figure 2A, (5)). In brain of doxycycline-treated animals, 50% knockdown was reached (Figure 2A) in comparison to 80% silencing achieved by employing the constitutive H1 promoter (5). The limited activity of the inducible shRNA construct in brain may reflect a lower local concentration of doxycycline (21). A weak activity of the shRNA construct was also seen in spleen and thymus (Figure 2A and data not shown), which is in accordance with similar results using the constitutive H1 promoter in the same chromosomal context (5). The reason for this phenomenon is unclear. In all other tissues, induction with doxycycline resulted in efficient repression of firefly luciferase activity, ranging between 50 and 90% gene silencing (Figure 2A, white bars).
###end p 54
###begin p 55
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 84 86 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 615 623 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
In previous experiments, we also tested the activity of U6-tet and H1-tet using the wt tetR in a similar configuration as described above (Figure 1B). Here we detected a high degree background shRNA activity in the absence of doxycycline, particularly in kidney and brain (Figure S1). In other organs such as liver, muscle and heart, leakiness seemed less pronounced, indicating that limited expression of tetR might be the reason for the incomplete block of RNAi in some tissues. Comparing the expression level of wt and codon optimized tetR in transfected ES cells by western blotting supported this speculation (Figure 1D).
###end p 55
###begin title 56
Generation of a reversible diabetes model
###end title 56
###begin p 57
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 114 131 114 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Diabetes mellitus</italic>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Insr)</italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 322 325 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 821 829 821 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1085 1093 1085 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1142 1146 1130 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Insr</italic>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
We next applied our H1-tet configuration for generating an inducible mouse model of insulin resistance and type 2 Diabetes mellitus. Six different shRNA sequences directed against the insulin receptor (Insr) mRNA were tested in the INSR expressing muscle cell line C2C12 (22). shRNA coding regions were cloned into the H1-tet expression vector pH1tetO (pIR1 to pIR6) and transiently transfected into C2C12 cells. Western blot analysis of protein extracts derived from transfected cells revealed a strong RNAi activity using constructs pIR5 and pIR6, leading to >80% reduction of INSR expression (Figure S2). The RMCE strategy (5) was subsequently adapted for targeted insertion shRNA sequence #IR5 under the control of the H1-tet promoter along with a constitutive expression cassette encoding the codon optimized itetR (Figure 3A). Recombinase mediated integration resulted in >90% correctly targeted ES cell clones upon transfection of the exchange vector (Figure S3A). Northern blot analysis of isolated ES cell clones showed a high level of doxycycline-dependent shRNA expression (Figure 3B), resulting in a approximately70% knockdown of Insr mRNA as quantified by real-time PCR analysis (Figure S3B). 
###end p 57
###begin p 58
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 565 573 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 763 771 755 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Recombinant ES cell clones were injected into tetraploid blastocysts (23) and 35 eight-week-old ES mice were derived within three months. Transgenic ES mice harboring expression cassettes for inducible shRNA expression were fed with increasing concentrations of doxycycline in the drinking water for 10 days and the degree of INSR knockdown was analyzed in liver, muscle, heart and brain. Western blot analysis revealed a near-complete removal of INSR in animals treated with 2 mg/ml doxycycline, whereas the expression of INSR in untreated controls was unaltered (Figure 3C). In liver and heart, 20 microg/ml doxycycline was sufficient for inducing the INSR knockdown. In contrast, 2 microg/ml doxycycline in the drinking water had no effect on INSR expression (Figure 3C).
###end p 58
###begin p 59
###xml 288 296 272 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 464 472 444 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 653 661 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
As a consequence of INSR knockdown, mice displayed signs of insulin resistance such as severe hyperglycemia. Blood glucose levels reached a maximum of approximately500 mg/dl at day 9 when treated with 20 microg/ml and at Day 5 when treated with 2 mg/ml doxycycline in the drinking water (Figure 3D), indicating a dosage-dependent progression of the disease. In contrast, treatment with 2 microg/ml doxycycline did not result in any change of blood glucose levels (Figure 3D). Control animals expressing an unrelated shRNA against firefly luciferase showed no alteration of glucose homeostasis, even when treated with high concentrations of doxycycline (Figure 3D). When crossed to wild-type C57BL/6 animals, INSR knockdown mice transmitted the shRNA transgene at mendelian ratios. Upon induction with 20 microg/ml doxycycline, shRNA-transgenic offspring displayed the same phenotype as parental mice (data not shown), indicating that the transgenes are not silenced following germ-line transmission.
###end p 59
###begin p 60
###xml 213 221 213 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 471 479 471 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
Upon removal of doxycycline from the drinking water, glucose levels declined within seven days and serum insulin returned to normal levels after 14 days, demonstrating the reversibility of the inducible promoter (Figure 4A and B). In these animals, glucose homeostasis was fully restored as confirmed by glucose tolerance testing (Figure 4C). Accordingly, discontinuation of doxycycline treatment resulted in the reappearance of INSR protein in the liver within 21 days (Figure 4D). 
###end p 60
###begin title 61
DISCUSSION
###end title 61
###begin p 62
###xml 279 285 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 357 363 357 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 171 186 <span type="species:ncbi:10090">transgenic mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 803 808 <span type="species:ncbi:10090">mouse</span>
In this work, we describe a straightforward method for the generation of drug-inducible knockdown mouse models. Several key issues for the state-of-the-art development of transgenic mice are addressed: (i) Reproducible transgene expression is warranted by the well-characterized rosa26 locus. (ii) High targeting efficiency of transgene constructs into the rosa26 locus is achieved by exploiting recombinase-mediated cassette exchange. (iii) Minimization of elaborated genetic modifications is allowed by a one-, rather than a multi-vector expression cassette. (iv) Tight and reversible regulation of shRNA expression is obtained by the usage of a codon-optimized tet-repressor. (v) Rapid generation of mice without further breeding is achieved by tetraploid embryo complementation. The type 2 diabetes mouse model described in this article illustrates the capability of this technology.
###end p 62
###begin p 63
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
The model for insulin resistance presented herein, exhibits several advantages over existing ones (10,11). First of all, induction of insulin resistance allows to circumvent potential confounding developmental effects or compensatory mechanisms altering the phenotype. Moreover, the temporal control of insulin receptor knockdown can provide further insights into the impact of environmental factors prior to the onset of the disease. Second, reversibility of hyperglycemia provides a unique model to mimic the effect of an ideal pharmacological intervention. Along this line, it has so far not been established to what extent perfect control of metabolism after onset of disease is successful to prevent occurrence and/or progression of diabetic complications or lead even to reversion of them. Therefore, this model will be of central importance to gain better insights into not only diabetic retinopathy, nephropathy, polyneuropathy, but also macrovascular complications such as myocardial infection and stroke. Third, the obvious doxycycline-dependent reduction of insulin repressor expression can be extended to carefully determine the critical threshold of insulin action necessary to (i) induce a compensatory increase in pancreatic beta-cell secretion and (ii) the occurrence of hyperglycemia. Thereby, these experiments will help to define the therapeutic efficiency required for reversal of clinically relevant insulin resistance. Finally, the single-allele configuration of the transgene circumvents time- and cost-consuming crossing experiments and makes it an ideal model for genetic screens for insulin resistance modulations, i.e. in a sensitized ENU-screen.
###end p 63
###begin p 64
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 166 171 166 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24 B25 B26 B27">24&#8211;27</xref>
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 152 161 <span type="species:ncbi:10090">nude mice</span>
Previous examples of doxycycline-inducible shRNA expression were restricted to in vitro applications or gene knockdown in tumor cells transplanted into nude mice (15,24-27). The activity of such systems in selected cell clones are not predictive for in vivo applications in which a tight control of RNAi needs to be achieved in different cell types and throughout development. In addition, these approaches included random transgenesis or lentiviral infection (28), each resulting in clones with unique, irreproducible shRNA expression patterns. Screening of several cell lines was required, which is laborious and time consuming. Therefore, these techniques, albeit being useful for the particular experiment presented, are not generally applicable for different biological questions.
###end p 64
###begin p 65
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 608 615 608 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Here, we show that a codon optimized rather than the wild-type tetR mediates tight control of the H1-tet promoter when integrated at the rosa26 locus. ShRNA-mediated gene knockdown is achieved within 10 days of doxycycline treatment. The system appeared to be reversible within 14 days after withdrawal of the inductor. This is in accordance with previous observations that saturation of a system with doxycycline is an intrinsically faster process than depletion (21,29). The kinetics of reversible gene modulation may be further improvable by applying other tetracycline derivates with a shorter half-life in vivo.
###end p 65
###begin p 66
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 438 445 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
###xml 774 779 <span type="species:ncbi:10090">mouse</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
###xml 856 864 <span type="species:ncbi:9606">patients</span>
The targeted insertion of all elements required for inducible shRNA expression into rosa26 using RMCE, and the subsequent ES cell injection using tetraploid blastocysts accelerate the generation of conditional knockdown mice significantly: 2 weeks for cloning of the RMCE exchange vector, 3 weeks for generating targeted ES cell clones, 4 weeks for the generation of newborn mice. Therefore, our system facilitates a rapid performance of in vivo gene function studies, providing a generally applicable tool for reverse mouse genetics research. Moreover, it permits the investigation of the effect of gene knockdown after the onset of a chronic or acute disease. This aspect is of particular interest for pharmaceutical drug target validation, as inducible gene silencing in mouse models of human disease can provide an ideal surrogate for the treatment of patients with antagonistic drugs. Even multiple dose regimes can be tested in preclinical studies by applying several rounds of induction. Furthermore, reversible knockdown of drug targets can help to distinguish target dependent from target independent effects of drug action.
###end p 66
###begin p 67
###xml 149 153 <span type="species:ncbi:10090">mice</span>
Taken together, the technology described provides a novel, rapidly applicable approach for the inducible and reversible analysis of gene function in mice, overcoming the limitations of recombinase-based conditional gene targeting.
###end p 67
###begin title 68
SUPPLEMENTARY DATA
###end title 68
###begin p 69
Supplementary Data are available at NAR Online.
###end p 69
###begin title 70
ACKNOWLEDGEMENTS
###end title 70
###begin p 71
We wish to thank Heidrun Kern, Maria da Silva, Marco Schneider (Artemis Pharmaceuticals GmbH, Cologne) and Sabine Jordan (Institute for Genetics, Cologne) for technical advice as well as Holger Kissel (Artemis Pharmaceuticals GmbH, Cologne) for critical reading of the manuscript. We also thank Rolf Sprengel (Max-Planck Institute for Medical Research, Heidelberg) for kindly providing the codon-optimized tet-repressor. This work was supported by Artemis Pharmaceuticals GmbH and the German Ministry for Education and Science (BMBF) grant no. 0313066H. Funding to pay the Open Access publication charge was provided by Artemis Pharmaceuticals GmbH, Cologne/Germany.
###end p 71
###begin p 72
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 72
###begin title 73
REFERENCES
###end title 73
###begin article-title 74
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Current issues in mouse genome engineering
###end article-title 74
###begin article-title 75
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Conditional knockout mice
###end article-title 75
###begin article-title 76
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Germline transmission of RNAi in mice
###end article-title 76
###begin article-title 77
###xml 99 114 <span type="species:ncbi:10090">transgenic mice</span>
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference
###end article-title 77
###begin article-title 78
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Single copy shRNA configuration for ubiquitous gene knockdown in mice
###end article-title 78
###begin article-title 79
Cre-lox-regulated conditional RNA interference from transgenes
###end article-title 79
###begin article-title 80
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Efficiency of RNA interference in the mouse hematopoietic system varies between cell-types and developmental stages
###end article-title 80
###begin article-title 81
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference
###end article-title 81
###begin article-title 82
Protein tyrosine phosphatase 1B inhibitors for diabetes
###end article-title 82
###begin article-title 83
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models of insulin resistance and type 2 diabetes
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models of insulin resistance
###end article-title 84
###begin article-title 85
###xml 102 107 <span type="species:ncbi:9606">human</span>
Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter
###end article-title 85
###begin article-title 86
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector
###end article-title 86
###begin article-title 87
Establishment of conditional vectors for hairpin siRNA knockdowns
###end article-title 87
###begin article-title 88
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Inducible shRNA expression for application in a prostate cancer mouse model
###end article-title 88
###begin article-title 89
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
###end article-title 89
###begin article-title 90
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Rapid generation of inducible mouse mutants
###end article-title 90
###begin article-title 91
A predictable ligand regulated expression strategy for stably integrated transgenes in mammalian cells in culture
###end article-title 91
###begin article-title 92
###xml 6 10 <span type="species:ncbi:10090">mice</span>
Green mice as a source of ubiquitous green cells
###end article-title 92
###begin article-title 93
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Blood and organ concentrations of tetracycline and doxycycline in female mice
###end article-title 93
###begin article-title 94
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
###end article-title 94
###begin article-title 95
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation
###end article-title 95
###begin article-title 96
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
###end article-title 96
###begin article-title 97
A versatile tool for conditional gene expression and knockdown
###end article-title 97
###begin article-title 98
###xml 131 139 131 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 90 95 <span type="species:ncbi:9606">human</span>
An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo
###end article-title 98
###begin article-title 99
Tumor inhibition by genomically integrated inducible RNAi-cassettes
###end article-title 99
###begin article-title 100
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour
###end article-title 100
###begin article-title 101
Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances
###end article-title 101
###begin title 102
Figures and Tables
###end title 102
###begin p 103
###xml 78 81 78 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 573 576 573 576 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 678 684 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 751 758 751 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 922 928 922 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 1075 1079 1075 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 1215 1218 1215 1218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 1406 1412 1406 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 1668 1669 1668 1669 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Schematic representation of the inducible system and gene targeting strategy. (A) Principle of tetR-mediated control of shRNA expression. Transcription of the RNA polymerase III-dependent promoter is blocked in cells expressing the tet repressor (tetR). Upon induction by doxycycline, tetR is removed from the tet-operator sequences (tetO) inserted into the promoter, allowing transcription of shFluc. ShRNA expression leads to RNAi-mediated knockdown of the target gene firefly luciferase. Renilla luciferase is used for reference to quantify firefly luciferase activity. (B) Scheme of the targeting strategy. ShRNA and reporter constructs were independently inserted into the rosa26 locus by homologous recombination in ES cells. Genes encoding the Renilla (Rluc) and firefly luciferases (Fluc) along with an adenovirus splice acceptor sequence and a polyadenylation signal (pA) were placed downstream of the endogenous rosa26 promoter. The Fluc-specific shRNA is expressed under the control of the U6-tet or H1-tet promoter, and terminated by five thymidines (shRNA). The loxP-sites flanking the shRNA expression cassettes were used to generate a negative control through cre-mediated recombination in ES cells. (C) Southern blot analysis of genomic DNA from transfected ES cell clones containing the shRNA- (lane #1 and #2) or the reporter-constructs (lanes #3 and #4). Homologous recombination at the rosa26 locus is detectable by using EcoRV-digested genomic DNA and probe 1, resulting in a 11.7 kb band for the wt and a 2.5 kb band for targeted allele. E: EcoRV; X: XbaI; neo: FRT-flanked neomycin resistance gene; hyg: FRT-flanked hygromycin resistance gene. (D) Western blot analysis from protein extracts of ES cells expressing either the wt tetR or the itetR using tetR- or beta-Actin-specific antiserum. Control: protein extracts from wt ES cells.
###end p 103
###begin p 104
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-tet</italic>
###xml 725 732 725 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 772 773 772 773 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 777 781 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-tet</italic>
###xml 817 818 817 818 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 851 855 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-tet</italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
Efficiency of H1/U6-shRNA-mediated firefly luciferase (Fluc) knockdown in mice expressing the codon-optimized tetR. Each configuration (control, H1-tet shRNA, U6-tet shRNA) was analyzed using two to four mice at the age of 8-10 weeks, respectively. Percentages of shRNA-mediated repression of firefly luciferase activity with standard error of the mean are shown for untreated controls (gray bars) and in animals upon 10 days feeding with 2 mg/ml doxycycline in the drinking water (white bars). In negative control animals (black bars), the shRNA expression cassettes are removed through cre-mediated recombination. Relative values of relative firefly luciferase expression level in different organs were calculated by using Renilla luciferases activities for reference. (A) H1-tet promoter-driven shRNA expression. (B) shRNA expression through the U6-tet promoter.
###end p 104
###begin p 105
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 61 64 61 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rosa26</italic>
###xml 361 362 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">insr</italic>
###xml 484 487 484 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 861 862 857 858 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1269 1270 1263 1264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 1302 1317 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1627 1631 <span type="species:ncbi:10090">mice</span>
Single vector configuration for INSR gene knockdown in vivo. (A) RMCE through Flpe-mediated recombination using the exchange vector generates the rosa26(RMCE exchanged) allele. The exchange vector carries the shRNA coding region under the control of the H1-tet promoter, the codon-optimized tetRi gene under the control of the CAGGS promoter and a truncated neoR gene for positive selection of clones upon successful RMCE. The insr-specific shRNA sequence IR5 is shown in the figure. (B) Detection of processed IR5-shRNA. shRNA-transgenic ES cell clone #1 (IR5) and control cells transfected with an RMCE exchange vector lacking the shRNA-expression cassette (control) were cultured in the absence and/or presence of 1 microg/ml doxycycline as indicated. RNA extracts were analyzed by northern blot using IR5-shRNA and 5S-rRNA-specific oligonucleotide probes. (C) Doxycycline dose response of INSR knockdown in mice. IR5 transgenic animals were treated in the absence or presence of 2 mug/ml, 20 mug/ml or 2 mg/ml doxycycline for 10 days, as indicated. Protein extracts were prepared from various tissues and subjected to western blot analysis using INSR- or AKT-specific antiserum. Control: protein extracts from animals carrying a firefly luciferase-specific shRNA. (D) Serum glucose levels in shRNA-transgenic mice treated with 2 mug/ml (triangles), 20 mug/ml (bars) or 2 mg/ml doxycycline in the drinking water (circles) for the indicated number of days. Control animals (rectangles) carry a firefly luciferase-specific shRNA construct. Serum glucose levels +/- SEM are shown. All assays were performed using groups of six mice at the age of two months.
###end p 105
###begin p 106
###xml 24 37 24 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hyperglycemia</italic>
###xml 250 251 246 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 350 351 346 347 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 455 456 449 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 695 696 687 688 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
###xml 506 521 <span type="species:ncbi:10090">transgenic mice</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
Reversible induction of hyperglycemia in mice. A group of six 2-month old, shIR5-transgenic mice were fed for 10 days with 20 microg/ml doxycycline in the drinking water and subsequently kept in the absence of doxycycline for the following 21 days. (A) Blood glucose levels were determined in venous blood samples at the indicated day of treatment. (B) Serum insulin concentrations were measured as indicated. Each bar represents the mean value +/- SEM. (C) Glucose tolerance test were performed using IR5-transgenic mice before (triangles) and 21 days after dox treatment (rectangles). Results are expressed as mean blood glucose concentration +/- SEM from at least six animals of each group. (D) Reversible knockdown of the insulin receptor using 20 microg/ml doxycycline for 10 days and 21 days after removal of dox in two independent mice. Protein extracts prepared from liver were subjected to western blot analysis using an INSR-specific antiserum and an AKT-specific antiserum.
###end p 106

